Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency

Europace

Volumn 15, Issue 8, 2013, Pages 1205-1209

  Pecha, Simon ^a   Aydin, Muhammed Ali ^a   Yildirim, Yalin ^a   Sill, Björn ^a   Reiter, Beate ^a   Wilke, Iris ^a   Reichenspurner, Hermann ^a   Treede, Hendrik ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

CIED infection; Pacemaker; Temporary pacing

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; ATRIOVENTRICULAR BLOCK; BACTERIAL INFECTION; BLOOD CULTURE; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; DEBRIDEMENT; DEFIBRILLATOR PACEMAKER; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEUKOCYTE COUNT; MALE; PACEMAKER DEPENDENCY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECANALIZATION; SUPINE POSITION; SURVIVAL RATE;

EID: 84880960543     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut031     Document Type: Article

References (19)

1. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: Calendar year 2005 an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol 2008;31: 1202-12
2. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010;33:705-11
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37
5. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48:590-1
6. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol 2011;58:1001-6
7. Braun MU, Rauwolf T, Bock M, Kappert U, Boscheri A, Schnabel A et al. Percutaneous lead implantation connected to an external device in stimulationdependent patients with systemic infection -A prospective and controlled study. Pacing Clin Electrophysiol 2006;29:875-9
8. Deharo JC, Quatre A, Mancini J, Khairy P, Le Dolley Y, Casalta JP et al. Long-Term outcomes following infection of cardiac implantable electronic devices: A prospective matched cohort study. Heart 2012;98:724-31
9. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010;121:458-77
10. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH III et al. Heart Rhythm Society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: This document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009;6:1085-104
11. Kratz JM, Toole JM. Pacemaker and internal cardioverter defibrillator lead extraction: A safe and effective surgical approach. Ann Thorac Surg 2010;90:1411-7
12. Farooqi FM, Talsania S, Hamid S, Rinaldi CA. Extraction of cardiac rhythm devices: Indications, techniques and outcomes for the removal of pacemaker and defibrillator leads. Int J Clin Pract 2010;64:1140-7
13. Arujuna A, Williams S, Whittaker J, Shetty A, Roy D, Bostock J et al. Trends, indications and outcomes of cardiac implantable device system extraction: A single UK centre experience over the last decade. Int J Clin Pract 2012;66:218-25
14. Pichlmaier M, Knigina L, Kutschka I, Bara C, Oswald H, Klein G et al. Complete removal as a routine treatment for any cardiovascular implantable electronic device-Associated infection. J Thorac Cardiovasc Surg 2011;142:1482-90
15. Nandyala R, Parsonnet V. One stage side-To-side replacement of infected pulse generators and leads. Pacing Clin Electrophysiol 2006;29:393-6
16. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8
17. Orsbourn G, Lever N, Harding SA. Use of tunnelled active fixation leads allows reliable temporary pacing over prolonged periods. Intern Med J 2008; 38:735-8
18. Lepillier A, Otmani A, Waintraub X, Ollitrault J, Le Heuzey J, Lavergne T. Temporary transvenous VDD pacing as a bridge to permanent pacemaker implantation in patients with sepsis and haemodynamically significant atrioventricular block. Europace 2012;14:981-5
19. Lever N, Ferguson JD, Bashir Y, Channon KM. Prolonged temporary cardiac pacing using subcutaneous tunnelled active-fixation permanent pacing leads. Heart 2003;89:209-10